Clinical trial Recruiting at 1 site Interventional Ages 18 and up

3- vs 5-Needle Genicular Nerve Block for Knee Osteoarthritis

Official title: A Randomized Controlled Trial Comparing the Effectiveness of 3-Needle vs 5-Needle of Genicular Nerve Block on Pain and Quality of Life in Knee Osteoarthritis

Run by Tanta University · NCT07853170 · Data updated 2026-11-12

This study tests whether a five-needle genicular nerve block provides better pain relief and quality of life than the traditional three-needle approach in adults with knee osteoarthritis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, El-Gharbia)
StatusRecruiting
StartedOctober 4, 2026
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedOctober 6, 2026
Trial IDNCT07853170 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with unilateral knee osteoarthritis (ACR criteria, Kellgren-Lawrence grade ≥2) who have had at least 3 months of conservative treatment and no recent knee injections or surgeries.

Probably not a fit

Patients whose KOA pain is driven by non-knee sources or who do not respond to genicular nerve blockade may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two genicular nerve block techniques in adults with unilateral knee osteoarthritis who have had at least three months of non-surgical care. Participants are randomized to receive either a 3-needle blockade targeting the superior medial, superior lateral, and inferior medial nerves or a 5-needle blockade that adds additional sensory branches. Outcomes focus on pain and quality of life, with eligibility restricted to KOA patients meeting Kellgren-Lawrence grade 2 or higher and without confounding knee conditions. The trial is led by Tanta University and will be conducted at a single site in Tanta, Egypt. The goal is to determine if the broader 5-needle approach offers superior clinical benefit compared with the standard 3-needle technique.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief and improved daily functioning from the preferred genicular nerve block approach.

How similar studies have gone: Prior genicular nerve block studies support nerve-targeted approaches, but direct 3- vs 5-needle comparison in KOA is less established and may be considered exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Both sexes.
* Patients with unilateral chronic knee pain for more than 3 months.
* Patients received conservative treatment for at least 3 months.
* Diagnosed Knee osteoarthritis (KOA) according to the American College of Rheumatology (ACR) criteria, and grade greater than or equal to Kellgren-Lawrence grade 2.

Exclusion Criteria:

* Chronic knee pain is due to causes other than KOA, such as connective tissue diseases, lumbar radicular neuropathy (spondylolisthesis, spinal stenosis), or sciatic pain.
* Knee effusion.
* Neuro/psychiatric disorders.
* History of intra-articular injection in the prior 3 months.
* Prior knee surgery.
* Active systemic or local knee infections; anticoagulant use.

Where it's running

  • Tanta University
    Tanta, El-Gharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.